Cargando…

N-acetylcysteine for the treatment of COVID-19 among hospitalized patients

Detalles Bibliográficos
Autores principales: Avdeev, Sergey N., Gaynitdinova, Viliya V., Merzhoeva, Zamira M., Berikkhanov, Zelimkhan G.-M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Infection Association. Published by Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8271031/
https://www.ncbi.nlm.nih.gov/pubmed/34252497
http://dx.doi.org/10.1016/j.jinf.2021.07.003
_version_ 1783720922067238912
author Avdeev, Sergey N.
Gaynitdinova, Viliya V.
Merzhoeva, Zamira M.
Berikkhanov, Zelimkhan G.-M.
author_facet Avdeev, Sergey N.
Gaynitdinova, Viliya V.
Merzhoeva, Zamira M.
Berikkhanov, Zelimkhan G.-M.
author_sort Avdeev, Sergey N.
collection PubMed
description
format Online
Article
Text
id pubmed-8271031
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The British Infection Association. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-82710312021-07-20 N-acetylcysteine for the treatment of COVID-19 among hospitalized patients Avdeev, Sergey N. Gaynitdinova, Viliya V. Merzhoeva, Zamira M. Berikkhanov, Zelimkhan G.-M. J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2022-01 2021-07-10 /pmc/articles/PMC8271031/ /pubmed/34252497 http://dx.doi.org/10.1016/j.jinf.2021.07.003 Text en © 2021 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Avdeev, Sergey N.
Gaynitdinova, Viliya V.
Merzhoeva, Zamira M.
Berikkhanov, Zelimkhan G.-M.
N-acetylcysteine for the treatment of COVID-19 among hospitalized patients
title N-acetylcysteine for the treatment of COVID-19 among hospitalized patients
title_full N-acetylcysteine for the treatment of COVID-19 among hospitalized patients
title_fullStr N-acetylcysteine for the treatment of COVID-19 among hospitalized patients
title_full_unstemmed N-acetylcysteine for the treatment of COVID-19 among hospitalized patients
title_short N-acetylcysteine for the treatment of COVID-19 among hospitalized patients
title_sort n-acetylcysteine for the treatment of covid-19 among hospitalized patients
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8271031/
https://www.ncbi.nlm.nih.gov/pubmed/34252497
http://dx.doi.org/10.1016/j.jinf.2021.07.003
work_keys_str_mv AT avdeevsergeyn nacetylcysteineforthetreatmentofcovid19amonghospitalizedpatients
AT gaynitdinovaviliyav nacetylcysteineforthetreatmentofcovid19amonghospitalizedpatients
AT merzhoevazamiram nacetylcysteineforthetreatmentofcovid19amonghospitalizedpatients
AT berikkhanovzelimkhangm nacetylcysteineforthetreatmentofcovid19amonghospitalizedpatients